Stock Taper
EARNINGS CALL ARCHIVE 3 CALLS ON FILE
BCAX — Bicara Therapeutics Inc. Common Stock
NASDAQ
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 11, 2026
REVENUE
$0
EPS
-$0.82 +11.8%
FREE CASH FLOW
-$44.3M -17.8%

No summary has been written for this call yet.